GO:0031435 mitogen-activated protein kinase kinase kinase binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031435 (mitogen-activated protein kinase kinase kinase binding) is a molecular function term describing the selective interaction of a protein with a MAP kinase kinase kinase (MAPKKK or MAP3K).
• This binding event is the entry point for scaffold-mediated assembly of MAPK signaling modules, as shown for JIP family proteins that bind multiple kinases including MAPKKKs.
• MAPKKK binding proteins such as JIP3 and JIP1 coordinate the spatial organization of JNK and p38 pathways, influencing neuronal and stress responses [3,7].
• TAK1 (MAP3K7) autophosphorylation and its interaction with binding partners regulate downstream p38 and JNK activation [5,8].
• Dysregulated MAPKKK binding contributes to cancer, inflammatory signaling, and viral pathogenesis, including rabies virus matrix protein hijacking of the TAK1-p38 axis.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of MAPKKK binding interfaces and their signaling consequences [1,2].
Description
Mitogen-activated protein kinase kinase kinase binding (GO:0031435) is a molecular function that defines the physical and functional interaction between a protein and a MAP kinase kinase kinase (MAPKKK, also called MAP3K). MAPKKKs are serine/threonine kinases that phosphorylate MAP kinase kinases (MAPKKs), which in turn activate MAP kinases such as JNK, p38, and ERK [5,8]. The binding event itself is not merely a passive association; it often determines substrate specificity, subcellular localization, and signal duration [3,7]. Researchers study this term because MAPKKK-binding proteins act as scaffolds, adaptors, or regulatory subunits that assemble signaling modules and shape cellular outcomes ranging from stress responses to apoptosis [3,7].
mitogen-activated protein kinase kinase kinase binding At A Glance
| GO ID | GO:0031435 |
|---|---|
| GO term | mitogen-activated protein kinase kinase kinase binding |
| Ontology | molecular_function |
| Synonym | MAPKKK binding |
| Definition | Binding to a mitogen-activated protein kinase kinase kinase, a protein that can phosphorylate a MAP kinase kinase. |
| Major function | Scaffolding and assembly of MAPK signaling modules; regulation of MAPKKK localization and activity. |
| Example binding partners | JIP1, JIP3, TAK1 (MAP3K7), and other MAPKKK-interacting proteins [3,5,7]. |
| Associated pathways | JNK, p38, and TAK1-NLK cascades [3,6,8]. |
What Is GO:0031435?
In the Gene Ontology, GO:0031435 is defined as binding to a mitogen-activated protein kinase kinase kinase, a protein that can phosphorylate a MAP kinase kinase. The synonym MAPKKK binding is used interchangeably. This term captures a molecular function: the selective, non-covalent interaction between a protein and a MAPKKK. It does not describe catalytic activity of the binding protein itself, but rather the ability to recognize and physically associate with a MAPKKK, thereby influencing MAPK cascade assembly and output [3,5].
Why Is mitogen-activated protein kinase kinase kinase binding Important in Cell Biology?
MAPKKK binding is a central node in signal transduction because it determines which MAPK cascade is activated, where it occurs, and how long it persists [3,7]. Scaffold proteins such as JIP family members bind MAPKKKs and MAPKKs simultaneously, creating insulated signaling complexes that prevent cross-talk and enhance specificity. Dysregulation of these interactions is linked to cancer, inflammatory diseases, and viral pathogenesis [4,6]. Understanding GO:0031435 therefore provides mechanistic insight into how cells convert diverse stimuli into precise transcriptional and apoptotic responses [1,2].
• Defines the molecular basis for scaffold-mediated assembly of JNK and p38 MAPK modules.
• Regulates TAK1 autophosphorylation and downstream p38 activation [5,8].
• Controls Wnt-5a/Ca2+ antagonism of Wnt/beta-catenin signaling via TAK1-NLK.
• Influences neuronal stress responses through JIP3 interaction with MAPK modules.
• Contributes to viral pathogenesis, e.g., rabies virus matrix protein hijacks TAK1 binding protein 2 to modulate p38.
• Provides targets for therapeutic intervention in cancer and inflammatory diseases [4,6].
• Enables experimental dissection of signaling specificity using CRISPR knockouts [1,2].
• Links ribosome collision stress responses to MAPK activation via ZAKalpha [1,2].
• Supports drug discovery efforts aimed at disrupting pathological protein-protein interactions.
• Facilitates synthetic biology approaches to rewire MAPK signaling.
Molecular Mechanism of mitogen-activated protein kinase kinase kinase binding
Recognition and binding of MAPKKK
In simple terms: A protein recognizes and grabs onto a MAPKKK.
Binding to a MAPKKK typically involves specific protein-protein interaction domains, such as those found in JIP scaffold proteins, which can simultaneously bind MAPKKKs and MAPKKs. This interaction is essential for assembling a functional kinase module and can determine substrate selectivity [3,7].
Scaffold-mediated complex assembly
In simple terms: Scaffold proteins hold the kinases together so they can pass signals efficiently.
JIP1 and JIP3 act as scaffolds that bind multiple components of the JNK and p38 pathways, including MAPKKKs, thereby enhancing signaling efficiency and specificity [3,7]. The scaffold does not catalyze phosphorylation but spatially organizes the kinases.
Activation of MAPKKK and downstream cascade
In simple terms: Once bound, the MAPKKK can turn on the next kinase in line.
TAK1 (MAP3K7) is activated by autophosphorylation within its activation loop, a process that can be regulated by binding partners. Activated TAK1 then phosphorylates MAPKKs, leading to p38 and JNK activation and downstream gene expression [5,8].
Regulation by autophosphorylation and cofactors
In simple terms: The binding protein can control how active the MAPKKK becomes.
TAK1 autophosphorylation is a key regulatory step, and binding proteins may influence this process. Additionally, the TAK1-NLK cascade functions in Wnt-5a/Ca2+ signaling to antagonize beta-catenin, illustrating pathway-specific regulation.
Integration with stress and immune signaling
In simple terms: This binding helps cells respond to stress and infections.
Ribosome collisions trigger general stress responses that involve MAPK signaling, and ZAKalpha recognizes stalled ribosomes through partially redundant sensor domains [1,2]. Viral proteins such as rabies virus matrix protein can hijack TAK1 binding protein 2 to modulate p38 and inhibit apoptosis.
Key Genes Involved in GO:0031435 mitogen-activated protein kinase kinase kinase binding
The following genes encode proteins that bind MAPKKKs or are MAPKKKs themselves, and they are central to research on GO:0031435.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAP3K7 (TAK1) | MAPKKK activated by autophosphorylation; binds TAB proteins | Central to p38/JNK activation and immune signaling [5,8] |
| MAPK8IP1 (JIP1) | Scaffold protein binding MAPKKKs and MAPKKs | Regulates JNK signaling and neuronal apoptosis |
| MAPK8IP3 (JIP3) | Scaffold protein interacting with MAPK modules | Neuronal stress and transport |
| MAPK8IP2 (JIP2) | Scaffold protein for MAPK pathways | Modulates JNK/p38 signaling |
| TAB1 | Regulatory subunit of TAK1 | Essential for TAK1 activation and p38 signaling [4,5] |
| TAB2 | Regulatory subunit of TAK1 | Hijacked by rabies virus matrix protein |
| TAB3 | Regulatory subunit of TAK1 | Modulates TAK1 activity |
| ZAK (MAP3K20) | MAPKKK sensing ribosome collisions | Stress response and cell fate [1,2] |
| NLK | Downstream kinase in TAK1-NLK cascade | Wnt/beta-catenin antagonism |
| MAP2K4 | MAPKK activated by MAPKKKs | JNK/p38 activation |
| MAP2K7 | MAPKK activated by MAPKKKs | JNK activation |
| MAPK8 (JNK1) | MAPK downstream of MAPKKK binding | Stress and apoptosis [3,7] |
| MAPK14 (p38alpha) | MAPK downstream of TAK1 | Inflammation and stress [5,8] |
| MAP3K1 | MAPKKK in JNK/ERK pathways | Cell proliferation and survival |
| MAP3K5 (ASK1) | MAPKKK in stress pathways | Apoptosis and inflammation |
| MAP3K11 (MLK3) | MAPKKK in JNK pathway | Neuronal signaling |
| MAP3K12 (DLK) | MAPKKK in neuronal stress | Axon regeneration |
How Is mitogen-activated protein kinase kinase kinase binding Regulated?
MAPKKK binding is regulated at multiple levels. Autophosphorylation of TAK1 within its activation loop is a critical step that can be influenced by binding partners. Scaffold proteins such as JIP1 and JIP3 can be phosphorylated or localized to specific cellular compartments, thereby modulating their interaction with MAPKKKs [3,7]. Additionally, the TAK1-NLK cascade is regulated by Wnt-5a/Ca2+ signaling, which antagonizes beta-catenin. Stress conditions, including ribosome collisions, can trigger ZAKalpha-dependent MAPK activation, linking translation stress to MAPKKK binding events [1,2].
mitogen-activated protein kinase kinase kinase binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAP3K7 (TAK1) | Inflammation, cancer | Knockout and point-mutation cell lines [5,8] |
| MAPK8IP3 (JIP3) | Neurodegeneration | Knockout neurons and knock-in tagged lines |
| TAB2 | Viral pathogenesis (rabies) | Overexpression and knockout models |
| ZAK (MAP3K20) | Stress response, ribosomopathy | Knockout and point-mutation models [1,2] |
| NLK | Developmental disorders | Knock-in reporter lines |
Cancer and inflammatory signaling
Dysregulated MAPKKK binding can lead to constitutive activation of JNK and p38 pathways, contributing to tumor progression and chronic inflammation [4,6]. TAK1 and its binding partners are frequently implicated in NF-kB and MAPK activation in cancer [5,8].
Neurodegeneration and neuronal stress
JIP3 and JIP1 scaffold proteins are critical for neuronal MAPK signaling, and their dysfunction has been linked to neurodegenerative processes [3,7]. ZAKalpha-mediated stress responses in neurons may also contribute to cell fate decisions [1,2].
Viral pathogenesis
Rabies virus matrix protein hijacks TAK1 binding protein 2 to modulate p38 MAPK, inhibiting apoptosis and promoting viral replication. This highlights how pathogens exploit MAPKKK binding interfaces.
Developmental disorders
The TAK1-NLK cascade functions in Wnt-5a/Ca2+ signaling to antagonize Wnt/beta-catenin, a pathway essential for development; disruption can lead to developmental abnormalities.
From mitogen-activated protein kinase kinase kinase binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MAPKKK binding affect JNK activation? | Knockout of scaffold gene (e.g., MAPK8IP1) |
| Does a point mutation in the binding interface disrupt signaling? | Point-mutation knock-in |
| Where does MAPKKK binding occur in cells? | Tagged knock-in (e.g., GFP) |
| Does overexpression of a binding partner activate p38? | Overexpression cell line |
| Which genes are essential for TAK1-mediated p38 activation? | CRISPR library screening [1,2] |
| How does viral protein hijack MAPKKK binding? | Viral infection with knockout cells |
How to Study the mitogen-activated protein kinase kinase kinase binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interaction | Validate MAPKKK binding |
| Western blot | Phosphorylation status | Measure p38/JNK activation [5,8] |
| CRISPR knockout | Loss-of-function phenotype | Test necessity of binding partner [1,2] |
| Knock-in tagging | Subcellular localization | Track MAPKKK binding in live cells |
| RNA-seq | Transcriptional changes | Identify downstream targets [1,2] |
| Proteomics | Protein complex composition | Discover novel binding partners |
| Library screening | Gene essentiality | Find regulators of MAPKKK binding [1,2] |
| Imaging | Spatial distribution | Visualize signaling complexes |
Co-immunoprecipitation and pull-down assays
These methods detect physical interactions between MAPKKKs and binding partners, confirming GO:0031435 activity [3,5].
Phospho-kinase profiling
Western blotting for phospho-p38, phospho-JNK, and phospho-MAPKKs measures downstream activation following binding events [5,8].
CRISPR knockout and knock-in
Generating knockout or tagged knock-in cell lines allows functional dissection of binding interfaces and localization [1,2,7].
Transcriptomics and proteomics
RNA-seq and mass spectrometry identify global changes in gene expression and protein complexes upon disruption of MAPKKK binding [1,2].
How CRISPR Can Be Used to Study GO:0031435 mitogen-activated protein kinase kinase kinase binding
Knockout
CRISPR knockout of genes encoding MAPKKK-binding proteins (e.g., MAPK8IP1, MAP3K7) can abolish specific signaling outputs, revealing their necessity in p38 or JNK activation [1,2,5].
Point Mutation
Introducing point mutations in the binding interface of a MAPKKK or its partner can disrupt interaction without affecting protein stability, allowing precise structure-function analysis.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci enables real-time tracking of MAPKKK binding complexes and their localization.
Overexpression
Overexpression of a MAPKKK-binding protein can amplify signaling or create a dominant-negative effect, useful for pathway activation studies.
How EDITGENE Supports mitogen-activated protein kinase kinase kinase binding Research
Researchers studying mitogen-activated protein kinase kinase kinase binding-related genes often need to determine whether a candidate gene is causally involved in pathway assembly, signal specificity, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for mitogen-activated protein kinase kinase kinase binding research.
Frequently Asked Questions About mitogen-activated protein kinase kinase kinase binding
What is GO:0031435?
GO:0031435 is the Gene Ontology molecular function term for mitogen-activated protein kinase kinase kinase binding, defined as binding to a MAPKKK, a protein that phosphorylates a MAP kinase kinase.
What genes are involved in mitogen-activated protein kinase kinase kinase binding?
Key genes include MAP3K7 (TAK1), MAPK8IP1 (JIP1), MAPK8IP3 (JIP3), TAB1, TAB2, and ZAK (MAP3K20), among others [3,4,5,7].
How does MAPKKK binding regulate p38 MAPK?
Binding proteins such as TAK1 and its regulatory subunits facilitate autophosphorylation and downstream activation of p38 MAPK, influencing gene expression and apoptosis [5,8].
What diseases are associated with MAPKKK binding?
Dysregulated MAPKKK binding is linked to cancer, inflammatory diseases, neurodegeneration, and viral pathogenesis such as rabies [4,6,7].
What methods study MAPKKK binding?
Co-immunoprecipitation, Western blotting, CRISPR knockout/knock-in, RNA-seq, and proteomics are commonly used [1,2,3,5].
Can CRISPR knockout help study MAPKKK binding?
Yes, CRISPR knockout of scaffold or MAPKKK genes can abolish specific signaling outputs, revealing their functional necessity [1,2].
What is the role of JIP proteins in MAPKKK binding?
JIP proteins act as scaffolds that bind MAPKKKs and MAPKKs, organizing JNK and p38 signaling modules [3,7].
How is TAK1 activated?
TAK1 is activated by autophosphorylation within its activation loop, a process regulated by binding partners such as TAB proteins.
What is the TAK1-NLK cascade?
The TAK1-NLK cascade functions in Wnt-5a/Ca2+ signaling to antagonize Wnt/beta-catenin, linking MAPKKK binding to developmental pathways.
How does rabies virus exploit MAPKKK binding?
Rabies virus matrix protein hijacks TAK1 binding protein 2 to modulate p38 MAPK, inhibiting apoptosis and promoting viral replication.
Conclusion
GO:0031435 (mitogen-activated protein kinase kinase kinase binding) is a fundamental molecular function that governs the assembly and specificity of MAPK signaling modules. Through scaffold proteins like JIP1 and JIP3, and regulatory subunits of TAK1, this binding event shapes cellular responses to stress, cytokines, and pathogens [3,5,7]. Dysregulation contributes to cancer, neurodegeneration, and viral pathogenesis, making it a compelling target for therapeutic intervention [4,6]. Advanced CRISPR models and multi-omics approaches will continue to illuminate the precise mechanisms and disease relevance of MAPKKK binding [1,2].
References
- 1. Wu CC et al.. 2020. Ribosome Collisions Trigger General Stress Responses to Regulate Cell Fate.. Cell 182(2):404-416.e14 PMID: 32610081
- 2. Vind AC et al.. 2020. ZAKα Recognizes Stalled Ribosomes through Partially Redundant Sensor Domains.. Mol Cell 78(4):700-713.e7 PMID: 32289254
- 3. Yasuda J et al.. 1999. The JIP group of mitogen-activated protein kinase scaffold proteins.. Mol Cell Biol 19(10):7245-54 PMID: 10490659
- 4. Sun J et al.. 2026. Rabies virus matrix protein hijacks the TGF-beta activated kinase 1 binding protein 2-p38 mitogen-activated protein kinase pathway to inhibit apoptosis and promote viral replication.. Int J Biol Macromol 349:150991 PMID: 41713525
- 5. Kishimoto K et al.. 2000. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop.. J Biol Chem 275(10):7359-64 PMID: 10702308
- 6. Ishitani T et al.. 2003. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.. Mol Cell Biol 23(1):131-9 PMID: 12482967
- 7. Kelkar N et al.. 2000. Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3.. Mol Cell Biol 20(3):1030-43 PMID: 10629060
- 8. Hanafusa H et al.. 1999. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression.. J Biol Chem 274(38):27161-7 PMID: 10480932
